Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 682
interventional 603
Observational 70
Registry 9

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 264
Drug|Radiation 49
Drug|Other 41
Biological 39
Drug|Procedure 26
Biological|Drug 19
Radiation 18
Procedure 14
Other 13
Device 12
Drug|Procedure|Radiation 10
Behavioral 9
Biological|Other|Procedure 7
Device|Drug 7
Drug|Other|Procedure 7
Drug|Other|Radiation 7
Drug|placebo 5
Biological|Drug|Other 4
Biological|Drug|Procedure 4
Biological|Drug|Radiation 4
Biological|Procedure 4
Biological|Drug|Other|Procedure 3
Biological|Other 3
Combination Product 3
Device|Radiation 3
Diagnostic Test 3
Drug|Other|Procedure|Radiation 3
Behavioral|Device 1
Biological|Device|Drug|Procedure 1
Biological|Device|Procedure 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Drug|Other|Radiation 1
Biological|Drug|placebo|Procedure|Radiation 1
Biological|Genetic|Other 1
Biological|Other|placebo 1
Biological|Radiation 1
Device|Drug|Other 1
Device|Drug|Procedure 1
Device|Drug|Radiation 1
Dietary Supplement|Drug 1
Drug|Genetic 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure 1
Drug|placebo|Procedure 1
Drug|placebo|Procedure|Radiation 1
Other|Procedure 1
Other|Procedure|Radiation 1
Other|Radiation 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 417
China 26
France 24
United States|Canada 15
NA 13
United States|Puerto Rico 13
Canada 10
Germany 7
Netherlands 7
Italy 5
Japan 5
Denmark 4
Switzerland 3
Taiwan 3
United States|Australia 3
Spain 2
United States|Australia|Canada 2
United States|Australia|Canada|New Zealand 2
United States|France 2
United States|Spain 2
Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Hungary|Italy|Netherlands|Poland|Spain|Sweden|United Kingdom 1
Australia|Austria|Belgium|Canada|Egypt|France|Germany|Hungary|Israel|Italy|Luxembourg|Netherlands|New Zealand|Portugal|Singapore|Spain|Sweden|Switzerland|United Kingdom 1
Australia|Belgium|Denmark|France|Italy|Poland|Spain|United Kingdom 1
Austria|Belgium|Croatia|Denmark|France|Germany|Italy|Norway|Poland|Portugal|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|France|Netherlands|Spain|Switzerland 1
Austria|Belgium|France|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Belgium|France|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Denmark|France|Germany|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
Belgium 1
Brazil|Cuba 1
Egypt 1
Finland 1
France|Hungary 1
France|United Kingdom 1
Israel 1
Mexico 1
Serbia 1
Spain|United Kingdom 1
United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Israel|Italy|Japan|Netherlands|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|France|Hungary|Spain|Thailand 1
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Australia|Canada|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|France|Germany|Netherlands|Spain 1
United States|Australia|France|Korea, Republic of|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|France|Netherlands|Switzerland 1
United States|Belgium|France|Netherlands 1
United States|Canada|Israel 1
United States|Canada|Netherlands|Puerto Rico|Switzerland 1
United States|Canada|Switzerland 1
United States|Denmark|Netherlands 1
United States|France|Spain 1
United States|Germany|Israel 1
United States|Germany|Spain 1
United States|Netherlands 1
United States|Switzerland 1

Sites per Study

Site_count Study_Count
1 336
2 44
3 25
4 15
5 16
6 16
7 7
8 12
9 21
10 14
11 12
12 12
13 6
14 2
15 4
16 2
17 4
18 2
19 3
20 1
21 4
22 3
23 2
24 1
28 1
29 1
33 1
34 1
36 1
39 2
42 1
43 1
47 1
53 1
69 1
74 1
89 1
96 1
101 1
106 1
110 1
111 2
112 1
113 1
114 1
116 1
117 1
118 1
126 1
137 1
145 1
152 1
161 1
167 1
168 1
180 1
229 1
230 1
261 1
308 1
1329 1

Phase

Phase Study_Count
Phase 1 215
Phase 2 186
Phase 1/Phase 2 86
N/A 68
Early Phase 1 23
Phase 3 18
Phase 2/Phase 3 4
Phase 4 3

Number of Arms

Number_of_Arms Count_of_Studies
1 326
2 122
3 35
4 17
5 7
6 5
7 2
8 2
9 1
10 1
12 1
37 1
NA 83

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0000 1.0000 3.00000 10.00000 1.0000 30.00 1.0000 100.0000
1st Qu. 11.0000 20.0000 18.00000 25.00000 32.0000 67.50 169.5000 110.0000
Median 20.0000 40.0000 30.00000 54.00000 50.0000 90.50 290.0000 120.0000
Mean 31.3913 110.9706 37.55838 65.41975 109.3812 115.25 315.2778 156.6667
3rd Qu. 30.0000 63.2500 49.00000 79.00000 91.0000 138.25 402.7500 185.0000
Max. 150.0000 3417.0000 295.00000 350.00000 6452.0000 250.00 712.0000 250.0000

Trial Group Type

group_type Group_Count
Experimental 792
NA 83
Active Comparator 65
Other 27
No Intervention 15
Placebo Comparator 7

Intervention Model

intervention_model Study_Count
Single Group Assignment 385
Parallel Assignment 141
NA 54
Sequential Assignment 23

Primary Purpose

primary_purpose Study_Count
Treatment 529
Diagnostic 31
Supportive Care 17
Basic Science 9
Other 8
NA 5
Prevention 2
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 27
France 9
China 5
NA 5
Canada 4
United States|Canada 3
Denmark 2
Germany 2
Japan 2
Belgium 1
Finland 1
Germany|Netherlands 1
Ireland 1
Korea, Republic of 1
Russian Federation 1
Spain 1
Switzerland 1
United Kingdom 1
United States|Denmark|Finland|Israel|Sweden|United Kingdom 1
United States|Italy 1

Sites per Study

Site_count Study_Count
1 55
2 4
3 2
4 2
6 2
15 1
17 1
38 1
41 1
66 1

Enrollment Metrics

Measure Observational
Min 5.0000
1st Qu 29.2500
Median 61.0000
Mean 583.5714
3rd Qu 178.7500
Max 17080.0000

Observation Model

observational_model Study_Count
Cohort 36
Case-Only 16
NA 9
Case-Control 3
Case Control 2
Family-Based 2
Case-Crossover 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 46
Retrospective 14
NA 6
Other 3
Cross-Sectional 1

Registries

Studies by Country

Country Study_Count
China 6
Belgium 1
Germany 1
Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 9

Enrollment Metrics

Measure Registries
Min 300.000
1st Qu 600.000
Median 1000.000
Mean 2405.556
3rd Qu 3000.000
Max 9000.000

Registry Model

observational_model Study_Count
Cohort 8
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 5
Other 4

Follow-up

target_duration Study_Count
120 Months 3
10 Years 2
24 Months 1
3 Years 1
36 Months 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04461002 Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. https://ClinicalTrials.gov/show/NCT04461002 Enrolling by invitation GCS Ramsay Santé pour l’Enseignement et la Recherche 2020-12-31
NCT04097535 Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI https://ClinicalTrials.gov/show/NCT04097535 Recruiting Imperial College London 2020-08-01
NCT03180697 The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas https://ClinicalTrials.gov/show/NCT03180697 Recruiting Zhujiang Hospital 2021-09-30
NCT03101813 International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository https://ClinicalTrials.gov/show/NCT03101813 Recruiting Children’s Hospital Medical Center, Cincinnati 2037-06-30
NCT02747407 Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors https://ClinicalTrials.gov/show/NCT02747407 Active, not recruiting Wake Forest University Health Sciences 2019-04-17
NCT02731521 Clinical Development of MR Spectroscopy and Imaging in Brain Cancers https://ClinicalTrials.gov/show/NCT02731521 Recruiting University of Texas Southwestern Medical Center 2020-12-31
NCT02728024 Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas https://ClinicalTrials.gov/show/NCT02728024 Completed Johannes Gutenberg University Mainz 2015-03-31
NCT02652897 Hemostasis Alterations in Neurosurgical Patients https://ClinicalTrials.gov/show/NCT02652897 Recruiting Hospitales Universitarios Virgen del Rocío 2019-02-28
NCT02607397 ROCOCO - Low Grade Glioma - Planning Study https://ClinicalTrials.gov/show/NCT02607397 Completed Maastricht Radiation Oncology 2017-03-31
NCT02023346 Prognostic Awareness and Patient-Physician Communication in Malignant Glioma https://ClinicalTrials.gov/show/NCT02023346 Completed Memorial Sloan Kettering Cancer Center 2018-10-30
NCT02558335 CTCs for High Grade Glioma https://ClinicalTrials.gov/show/NCT02558335 Completed Abramson Cancer Center of the University of Pennsylvania 2017-04-30
NCT02391246 Radionecrosis and FDG PET https://ClinicalTrials.gov/show/NCT02391246 Recruiting Ottawa Hospital Research Institute 2020-03-31
NCT02388659 Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas https://ClinicalTrials.gov/show/NCT02388659 Recruiting University of Texas Southwestern Medical Center 2020-12-31
NCT02300532 Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study) https://ClinicalTrials.gov/show/NCT02300532 Completed Eisai Inc. 2014-07-10
NCT02300506 Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma https://ClinicalTrials.gov/show/NCT02300506 Completed Eisai Inc. 2016-07-10
NCT02186262 Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas https://ClinicalTrials.gov/show/NCT02186262 Completed Turku University Hospital 2017-12-31
NCT01811524 The Etiology and Progression of Brain Tumors https://ClinicalTrials.gov/show/NCT01811524 Completed Tampere University Hospital 2009-12-31
NCT01417507 Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery https://ClinicalTrials.gov/show/NCT01417507 Completed Radiation Therapy Oncology Group 2014-12-31
NCT04423094 Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas https://ClinicalTrials.gov/show/NCT04423094 Completed University Hospital, Montpellier 2019-03-01
NCT04346472 Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas https://ClinicalTrials.gov/show/NCT04346472 Completed University Hospital, Montpellier 2019-12-30
NCT04216537 Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas https://ClinicalTrials.gov/show/NCT04216537 Recruiting The First Affiliated Hospital of Zhengzhou University 2025-01-01
NCT04215211 MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence https://ClinicalTrials.gov/show/NCT04215211 Recruiting The First Affiliated Hospital of Zhengzhou University 2027-01-01
NCT04194593 Biomarker-based Algorithm for Diagnosis of Glioma https://ClinicalTrials.gov/show/NCT04194593 Active, not recruiting Hospices Civils de Lyon 2020-03-01
NCT04122521 Radiogenomic and Prognosis Analysis in Glioma https://ClinicalTrials.gov/show/NCT04122521 Recruiting Asan Medical Center 2021-02-28
NCT04055688 Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas https://ClinicalTrials.gov/show/NCT04055688 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-12-17
NCT04013828 Treatment Decision-making in Patients With Recurrent High-grade Glioma https://ClinicalTrials.gov/show/NCT04013828 Recruiting Odense University Hospital 2020-07-31
NCT04001257 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma https://ClinicalTrials.gov/show/NCT04001257 Completed University Hospital, Brest 2019-09-17
NCT04000048 Molecular Heterogeneity in Multilobar Low-grade Gliomas https://ClinicalTrials.gov/show/NCT04000048 Recruiting University Hospital, Montpellier 2020-06-30
NCT03973892 Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy https://ClinicalTrials.gov/show/NCT03973892 Completed Fondation Ophtalmologique Adolphe de Rothschild 2016-01-31
NCT03949192 Efficacy of Kangliuwan for Recurrent Grade IV Glioma https://ClinicalTrials.gov/show/NCT03949192 Recruiting Xuanwu Hospital, Beijing 2021-06-30
NCT03091270 ZOOMit-fMRI Identifies Motor Functional Cortex https://ClinicalTrials.gov/show/NCT03091270 Recruiting Beijing Neurosurgical Institute 2022-01-01
NCT03877861 Validation of Readibandâ„¢ Actigraph and Associated Sleep/Wake Classification Algorithms https://ClinicalTrials.gov/show/NCT03877861 Recruiting Allina Health System 2020-12-31
NCT03865355 Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients https://ClinicalTrials.gov/show/NCT03865355 Recruiting Novosibirsk State University 2024-04-11
NCT02965144 Long Term Survivors of High-grade Glioma and Their Caregivers https://ClinicalTrials.gov/show/NCT02965144 Completed Rigshospitalet, Denmark 2017-06-30
NCT03706625 Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment https://ClinicalTrials.gov/show/NCT03706625 Recruiting Assistance Publique - Hôpitaux de Paris 2021-10-31
NCT03698201 Blood Biomarker Signature in Glioma https://ClinicalTrials.gov/show/NCT03698201 Recruiting Cancer Trials Ireland 2022-07-31
NCT03677999 Spectroscopic Magnetic Resonance Imaging of Glioma https://ClinicalTrials.gov/show/NCT03677999 Recruiting University of Minnesota 2024-09-14
NCT03593993 A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas https://ClinicalTrials.gov/show/NCT03593993 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2021-05-19
NCT03496181 Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently https://ClinicalTrials.gov/show/NCT03496181 Recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT01225003 Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas https://ClinicalTrials.gov/show/NCT01225003 Completed Universitaire Ziekenhuizen Leuven NA
NCT01212731 Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study https://ClinicalTrials.gov/show/NCT01212731 Completed Abramson Cancer Center of the University of Pennsylvania 2015-08-31
NCT01191346 Radiation Planning Study for High Grade Brain Tumors https://ClinicalTrials.gov/show/NCT01191346 Completed University of Cincinnati 2013-03-31
NCT01138813 Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145) https://ClinicalTrials.gov/show/NCT01138813 Completed Merck Sharp & Dohme Corp. 2010-02-28
NCT01106794 Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma https://ClinicalTrials.gov/show/NCT01106794 Recruiting Children’s National Research Institute 2025-04-30
NCT01004523 Study of Tissue and Blood Samples From Patients With Low-Grade Glioma https://ClinicalTrials.gov/show/NCT01004523 Completed Alliance for Clinical Trials in Oncology 2013-03-31
NCT00967200 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors https://ClinicalTrials.gov/show/NCT00967200 Completed University Hospital, Montpellier 2009-07-31
NCT00939315 Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy https://ClinicalTrials.gov/show/NCT00939315 Completed University of Lausanne Hospitals 2016-01-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00899834 DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma https://ClinicalTrials.gov/show/NCT00899834 Completed St. Jude Children’s Research Hospital 2015-08-31
NCT00942760 Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas https://ClinicalTrials.gov/show/NCT00942760 Completed Dartmouth-Hitchcock Medical Center 2011-03-31
NCT01009307 Study of Blood and Cheek Cell Samples From Patients With Glioma https://ClinicalTrials.gov/show/NCT01009307 Completed University of California, San Francisco 2006-07-31
NCT02632370 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor https://ClinicalTrials.gov/show/NCT02632370 Completed Icahn School of Medicine at Mount Sinai 2018-12-31
NCT00339352 A Family Study of Adults With Glioma https://ClinicalTrials.gov/show/NCT00339352 Completed National Institutes of Health Clinical Center (CC) NA
NCT02473484 Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas https://ClinicalTrials.gov/show/NCT02473484 Completed University Hospital, Lille 2017-10-31
NCT00705198 Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062) https://ClinicalTrials.gov/show/NCT00705198 Completed Merck Sharp & Dohme Corp. 2016-07-31
NCT00561873 Nimotuzumab in Children With HGG https://ClinicalTrials.gov/show/NCT00561873 Completed Oncoscience AG NA
NCT00561691 Nimotuzumab in Children With Intrinsic Pontine Glioma https://ClinicalTrials.gov/show/NCT00561691 Completed Oncoscience AG NA
NCT00418899 Gliogene: Brain Tumor Linkage Study https://ClinicalTrials.gov/show/NCT00418899 Active, not recruiting M.D. Anderson Cancer Center 2022-09-01
NCT00352820 Experience of Brain Tumor Caregivers https://ClinicalTrials.gov/show/NCT00352820 Completed M.D. Anderson Cancer Center 2006-12-31
NCT00283569 Genetic Epidemiology of Adult Onset Glioma https://ClinicalTrials.gov/show/NCT00283569 Completed Kentuckiana Cancer Institute 2010-01-31
NCT00214175 Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy https://ClinicalTrials.gov/show/NCT00214175 Completed University of Wisconsin, Madison 2011-01-31
NCT00201903 The Roles of Tissue Factor in Malignant Gliomas https://ClinicalTrials.gov/show/NCT00201903 Completed Ontario Clinical Oncology Group (OCOG) NA
NCT00137488 Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) https://ClinicalTrials.gov/show/NCT00137488 Completed AHS Cancer Control Alberta 2007-12-31
NCT00125710 Comparative 2-D Tumor Analysis in Familial Gliomas https://ClinicalTrials.gov/show/NCT00125710 Completed AHS Cancer Control Alberta 2012-08-31
NCT00125697 Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy https://ClinicalTrials.gov/show/NCT00125697 Completed AHS Cancer Control Alberta 2015-06-30
NCT00059020 The Role of Gene Changes in Brain Tumor Formation and Growth https://ClinicalTrials.gov/show/NCT00059020 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001171 Evaluation of Factors in Human Brain Tumors https://ClinicalTrials.gov/show/NCT00001171 Completed National Institutes of Health Clinical Center (CC) NA
NCT00285324 Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis https://ClinicalTrials.gov/show/NCT00285324 Completed National Institutes of Health Clinical Center (CC) NA
NCT00009035 Natural History of Patients With Brain and Spinal Cord Tumors https://ClinicalTrials.gov/show/NCT00009035 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001148 Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor https://ClinicalTrials.gov/show/NCT00001148 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02686229 Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas https://ClinicalTrials.gov/show/NCT02686229 Recruiting University of Ulm 2020-12-31
NCT02619890 Brain Glioma Registry Combining Clinical and Imaging Information https://ClinicalTrials.gov/show/NCT02619890 Recruiting Asan Medical Center 2040-12-31
NCT03849430 Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients https://ClinicalTrials.gov/show/NCT03849430 Recruiting Universitaire Ziekenhuizen Leuven 2030-01-01
NCT04220424 Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis https://ClinicalTrials.gov/show/NCT04220424 Recruiting The First Affiliated Hospital of Zhengzhou University 2021-01-01
NCT04217044 Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence https://ClinicalTrials.gov/show/NCT04217044 Recruiting The First Affiliated Hospital of Zhengzhou University 2027-01-01
NCT04217018 MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence https://ClinicalTrials.gov/show/NCT04217018 Recruiting The First Affiliated Hospital of Zhengzhou University 2027-01-01
NCT04215224 Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence https://ClinicalTrials.gov/show/NCT04215224 Recruiting The First Affiliated Hospital of Zhengzhou University 2027-01-01
NCT04216550 Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas https://ClinicalTrials.gov/show/NCT04216550 Recruiting The First Affiliated Hospital of Zhengzhou University 2025-01-01
NCT03750890 Visual Study of Molecular Genotype in Glioma Evolution https://ClinicalTrials.gov/show/NCT03750890 Recruiting Tongji Hospital 2021-12-31